Clinically meaningful responses achieved with tralokinumab in adults with moderate-to-severe atopic dermatitis who did not meet IGA 0/1 at initial 16-week treatment
Authors: Eric Simpson, Andrew Blauvelt, Jonathan I Silverberg, Michael Cork, Norito Katoh, Thomas Mark, Shannon Schneider, Andreas Wollenberg